The mechanisms to maintain telomere length by telomerase in cancer cells include mutation of the TERT promoter, abnormal amplification of the TERT and TERC genes, rearrangements of the TERT gene, and genetic variants of the TERT gene and its promoter (Gaspar et al., 2018). This evidence concerns the gene TERT and cancer.